The five pathways: every savings initiative is one of these

Every supply chain initiative — all of them, across every category in the library — executes through one of five pathways. Naming the pathway before kickoff is the highest-leverage minute in the project, because the pathway determines everything downstream: which stakeholders must be in the room, what evidence has to exist, how long the work takes, and where it can die. Initiatives that stall have usually skipped this step — commodity tactics aimed at a physician-preference category, or a renegotiation launched with no benchmark and no timing leverage.

Competitive RFP. Put the category out to bid. The move when products are commodity-equivalent, several credible suppliers exist, and switching costs are manageable. The work is a clean specification, a crosswalk between catalogs, and a disciplined award. Its power is real competition; its risk is underestimating conversion effort after the award.

GPO optimization. Get everything the contract you already have will give: the right tier, a signed letter of commitment, compliance above the thresholds, off-contract spend pulled back on. No supplier change, no clinical change — often the fastest pathway on the board because the terms already exist and only attention is missing.

Contract renegotiation. Keep the incumbent, change the terms. The move when switching is impractical or the relationship is worth keeping — executed with a benchmark in hand and timed to the notice window, where the leverage lives. Escalator caps, price protection, and substitution rights ride along by default.

Physician-preference items. The implant-and-device world, where individual clinician preference drives the choice. Runs on physician engagement with the category’s economics — transparent benchmarks, capped pricing structures, surgeons co-owning the terms. Slowest pathway, largest single-category stakes, and completely different stakeholders from the other four.

Internal process improvement. The waste is not the price; it is the usage. Standardizing duplicative products, correcting par levels, converting to reprocessed or bulk formats, tightening substitution discipline. No supplier negotiation at all — which is why it is often invisible to teams whose only tool is negotiating.

The choice usually announces itself from a handful of cues: how commodity-equivalent the products are, how concentrated the supplier base is, whether clinical preference governs the choice, where the contract sits in its term, and whether the variance in your data is price or usage. Some categories legitimately support two pathways — a GPO optimization now, a competitive bid at term end — and sequencing them is strategy, not indecision.

This is what the playbook library operationalizes: each category names its pathway up front, then carries the pathway-specific execution detail — the savings math, the stakeholder map, the objections that will come and the responses that work. The five pathways are the method; the playbooks are the method applied, category by category.